PPARG and hepatocellular carcinoma: Zhewen et al. revealed that relationship between PPAR-γ and tumour microenvironment (TME)-related immunosuppression, wherein the drug resistance of immune checkpoint inhibitors (ICIs) in HCC is impacted16.